Canertinib
|
卡奈替尼
|
267243-28-7
|
Cenisertib
|
R763(AS-703569)
|
871357-89-0
|
AV-412
|
AV 412
|
451493-31-5
|
M-110
|
CS-2124
|
1395048-49-3
|
Erlotinib D6 hydrochloride
|
埃羅替尼-D6 鹽酸鹽
|
1189953-78-3
|
Pyrotinib dimaleate
|
馬來酸吡咯替尼
|
1397922-61-0
|
Citronellol
|
香茅醇
|
106-22-9
|
RSVA405
|
化合物RSVA 405
|
140405-36-3
|
JAK3-IN-6
|
JAK3-IN-6
|
1443235-95-7
|
Cridanimod
|
吖啶酮乙酸
|
38609-97-1
|
RTC-5
|
RTC-5
|
1423077-49-9
|
STAT3-IN-3
|
STAT3-IN-3
|
2361304-26-7
|
Sodium dichloroacetate
|
二氯乙酸鈉
|
2156-56-1
|
3-Indolepropionic acid
|
吲哚-3-丙酸
|
830-96-6
|
Mavelertinib
|
PF-06747775
|
1776112-90-3
|
DL-Norvaline
|
DL-正纈氨酸
|
760-78-1
|
Almonertinib
|
阿美替尼
|
1899921-05-1
|
STAT3-IN-1
|
STAT3-IN-1
|
2059952-75-7
|
AS2863619
|
AS2863619
|
2241300-51-4
|
Epertinib hydrochloride
|
EPERTINIB HYDROCHLORIDE
|
2071195-74-7
|
UC-514321
|
化合物UC-514321
|
299420-83-0
|
Tyrphostin AG30
|
酪氨酸磷酸化抑制劑 AG 30
|
122520-79-0
|
Protosappanin A
|
原蘇木素A
|
102036-28-2
|
Nitroflurbiprofen
|
158836-71-6
|
158836-71-6
|
(R)-Lisofylline
|
1-(5-hydroxyhexyl)-3,7-dimethyl-purine-2,6-dione
|
100324-81-0
|
Theliatinib
|
席栗替尼
|
1353644-70-8
|
PF-06651600
|
利特昔替尼
|
1792180-81-4
|
INCB053914 phosphate
|
CS-2873
|
2088852-47-3
|
JND3229
|
JND3229
|
2260886-64-2
|
Dupilumab
|
度匹魯單抗
|
1190264-60-8
|
Benzyl butyl phthalate
|
鄰苯二甲酸丁芐酯
|
85-68-7
|
Pim1/AKK1-IN-1
|
N-[5-(4-氰基苯基)-1H-吡咯并[2,3-B]吡啶-3-基]-3-吡啶甲酰胺
|
1093222-27-5
|
STAT5-IN-1
|
STAT5 Inhibitor
|
285986-31-4
|
FR-188582
|
189699-82-9
|
189699-82-9
|
AZD4205
|
AZD4205
|
2091134-68-6
|
PF-06263276
|
PF-06263276 (PF 6263276)
|
1421502-62-6
|
Reslizumab
|
RESLIZUMAB
|
241473-69-8
|
Tyk2-IN-5
|
TYK2-IN-5
|
1797432-62-2
|
G5-7
|
化合物JAK2 INHIBITOR G5-7
|
939681-36-4
|
BMS-690514
|
(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇
|
859853-30-8
|
HO-3867
|
HO-3867
|
1172133-28-6
|
Phenidone
|
菲尼酮
|
92-43-3
|
Neoseptin 3
|
1622863-21-1
|
1622863-21-1
|
Pyrotinib Racemate
|
1246089-97-3
|
1246089-97-3
|
Almonertinib hydrochloride
|
HS-10296 HYDROCHLORIDE
|
2134096-03-8
|
SC99
|
SC-99
|
882290-02-0
|
AG-1478
|
AG1478
|
153436-53-4
|
Pelargonidin chloride
|
氯化花葵素
|
134-04-3
|
Bropirimine
|
溴匹立明
|
56741-95-8
|
AV-412 free base
|
AV-412
|
451492-95-8
|
Fedratinib hydrochloride hydrate
|
TG-101348
|
1374744-69-0
|
HJC0152 hydrochloride
|
2-(2-氨基乙氧基)-5-氯-N-(2-氯-4-硝基苯基)苯甲酰胺鹽酸鹽
|
1420290-99-8
|
EGFR-IN-8
|
EGFR-IN-8
|
2407957-87-1
|
Benralizumab
|
BENRALIZUMAB
|
1044511-01-4
|
SHR0302
|
化合物SHR0302
|
1445987-21-2
|
Ustekinumab
|
烏司奴單抗
|
815610-63-0
|
Phenethyl ferulate
|
阿魏酸苯乙酯
|
71835-85-3
|
PD-161570
|
PD-161570;PF-1480232
|
192705-80-9
|
ARRY-380 (analog )
|
ARRY-380
|
937265-83-3
|
Momelotinib sulfate
|
N-(氰基甲基)-4-[2-[[4-(4-嗎啉基)苯基]氨基]-4-嘧啶基]苯甲酰胺硫酸鹽(1:2)
|
1056636-06-6
|
PD-089828
|
PD089828
|
179343-17-0
|
BD750
|
2-(2-Benzothiazolyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol
|
892686-59-8
|
HKI-357
|
HKI 357
|
848133-17-5
|
SMI-16a
|
PIM1/2 KINASE INHIBITOR VI
|
587852-28-6
|
TyK2-IN-2
|
2098466-94-3
|
2098466-94-3
|
FM-381
|
(E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE
|
2226521-65-7
|
D-Kynurenine
|
犬尿氨酸
|
13441-51-5
|
TAS6417
|
齊帕勒替尼
|
1661854-97-2
|
JAK/HDAC-IN-1
|
JAK/HDAC-IN-1
|
2284621-75-4
|
Hydroxychloroquine
|
羥基氯喹
|
118-42-3
|
NLRP3-IN-2
|
4-[2-(5-氯-2-甲氧基苯甲酰氨基)乙基]苯磺酰胺
|
16673-34-0
|
SH5-07
|
1456632-41-9
|
1456632-41-9
|
MTX-211
|
MTX-211
|
1952236-05-3
|
STAT5-IN-2
|
STAT5-IN-2
|
2111834-61-6
|
EGFR-IN-11
|
EGFR-IN-11
|
2463200-44-2
|
SGI-1776
|
SGI-1776
|
1025065-69-3
|
2,5-Di-tert-butylhydroquinone
|
2,5-二特丁基對苯二酚
|
88-58-4
|
Tesevatinib
|
XL-647
|
781613-23-8
|
Durvalumab
|
德瓦魯單抗
|
1428935-60-7
|
Atezolizumab
|
阿特珠單抗
|
1380723-44-3
|
Methyl Salicylate
|
水楊酸甲酯
|
119-36-8
|
EGFR-IN-5
|
EGFR-IN-5
|
2225887-26-1
|
Afatinib impurity 11
|
無中文名稱
|
1402086-20-7
|
BMS-599626 Hydrochloride
|
BMS-599626
|
873837-23-1
|
TP-3654
|
TP3654
|
1361951-15-6
|
BP-1-102
|
4-(N-(4-環(huán)己基芐基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羥基苯甲酸
|
1334493-07-0
|
TX1-85-1
|
TX1-85-1
|
1603845-32-4
|
CCT365623 hydrochloride
|
CCT365623
|
2126136-98-7
|
RG13022
|
RG-13022
|
136831-48-6
|
PF-06700841 P-Tosylate
|
CS-2860
|
2140301-96-6
|
AS2863619 free base
|
AS2863619 free base
|
2241300-50-3
|
EMI56
|
EMI56
|
2414374-41-5
|
Gefitinib-based PROTAC 3
|
Gefitinib-based PROTAC 3
|
2230821-27-7
|
SI-109
|
|
2429877-30-3
|
PKI-166
|
PKI 166
|
187724-61-4
|
CGP52411
|
CGP 52411
|
145915-58-8
|
SC57666
|
158959-32-1
|
158959-32-1
|
inS3-54A18
|
328998-53-4
|
328998-53-4
|
Pamicogrel
|
帕米甘草
|
101001-34-7
|
RO8191
|
8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE
|
691868-88-9
|